Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02435771 · ClinicalTrials.gov registry record · Phase 4
Efficacy Of Ergocalciferol In Adults According To BMI
A Phase 4 study, sponsored by Walter Reed National Military Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
NCT02435771: Clinical Trial Phase 4 study, sponsored by Walter Reed National Military Medical Center.
NCT02435771 is a Phase 4 study that was terminated before completion, run by Walter Reed National Military Medical Center. The registered enrollment target is 44 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02435771, a Phase 4 study, was terminated before completion, sponsored by Walter Reed National Military Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
Study Summary
Vitamin D insufficiency is an increasing trend in the United States. According to the NHANES data collection there was a near doubling of patients with vitamin D deficiency in 10 years. Vitamin D deficiency is associated with several adverse outcomes such as increased fractures, certain microbial diseases, cardiovascular diseases, and metabolic dysfunction. The increasing prevalence of vitamin D deficiency has been attributed to the increasing prevalence of obesity. Several studies have shown that obese patients have lower 25-OH vitamin D (25-OHD) levels compared to nonobese patients and obese patients require more vitamin D compared to nonobese patients. The most commonly prescribed medication to replete vitamin D deficiency is oral ergocalciferol. To date, no prospective trials have been published to evaluate a standard protocol in the treatment of vitamin D insufficiency in adults.
Interventions
- DRUG Ergocalciferols
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2011-07 |
| Est. Completion | 2017-04 |
| Phase | Phase 4 |
Why NCT02435771 stopped before completion
NCT02435771 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Ergocalciferols is the first listed.
NCT02435771 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02435771 about?
NCT02435771 is a clinical study titled "Efficacy Of Ergocalciferol In Adults According To BMI". Vitamin D insufficiency is an increasing trend in the United States. According to the NHANES data collection there was a near doubling of patients with vitamin D deficiency in 10 years. Vitamin D deficiency is associated with several adverse outcomes such as increased fractures, certain microbial di...
What is the current status of trial NCT02435771?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2011-07. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02435771?
The interventions under investigation include: Ergocalciferols (DRUG).
Who is sponsoring clinical trial NCT02435771?
This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02435771's enrollment target sits among peer trials
44 1363rd of 2000 higher than 630 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia